| Dr Lark Greenwald Guss, MD | |
|
510 S Cowley St Ste 200, Spokane, WA 99202-1332 | |
| (509) 456-8444 | |
| (509) 455-9227 |
| Full Name | Dr Lark Greenwald Guss |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 510 S Cowley St Ste 200, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275973398 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Specialists Of Spokane | 2567540503 | 7 |
News Archive
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended June 30, 2010.
More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.
› Verified 3 days ago
| Entity Name | Walter L Williams |
|---|---|
| Entity Type | Practitioner - Dermatology |
| Entity Identifiers | NPI Number: 1841269248 PECOS PAC ID: 4385610757 Enrollment ID: I20040908000156 |
News Archive
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended June 30, 2010.
More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.
› Verified 3 days ago
| Entity Name | Dermatology Specialists Of Spokane |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912179599 PECOS PAC ID: 2567540503 Enrollment ID: O20080416000472 |
News Archive
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended June 30, 2010.
More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lark Greenwald Guss, MD 510 S Cowley St, Spokane, WA 99202-1332 Ph: (509) 456-8444 | Dr Lark Greenwald Guss, MD 510 S Cowley St Ste 200, Spokane, WA 99202-1332 Ph: (509) 456-8444 |
News Archive
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended June 30, 2010.
More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.
› Verified 3 days ago
William Philip Werschler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 104 W 5th Ave, 330w, Spokane, WA 99204 Phone: 509-624-1184 Fax: 509-625-1449 | |
Daniel Bowen Baird, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 | |
Dr. Michael E Ryan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5901 N Lidgerwood St, Ste 118, Spokane, WA 99208 Phone: 509-483-2828 Fax: 509-484-7882 | |
James Keith Parker, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5905 N Mayfair St Ste 200, Spokane, WA 99208 Phone: 509-456-7414 Fax: 800-247-9519 | |
Myron Zhang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 E 5th Ave Ste 4, Spokane, WA 99202 Phone: 509-342-3945 Fax: 509-755-6580 | |
Benjamin Hsu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Northwest Dermatology, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 |